Premium
Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections
Author(s) -
Dossin O.,
Gruet P.,
Thomas E.
Publication year - 1998
Publication title -
journal of small animal practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.7
H-Index - 67
eISSN - 1748-5827
pISSN - 0022-4510
DOI - 10.1111/j.1748-5827.1998.tb03652.x
Subject(s) - medicine , vomiting , respiratory system , clavulanic acid , anesthesia , surgery , amoxicillin , antibiotics , microbiology and biotechnology , biology
One hundred and three cats presenting with clinical signs of feline acute upper respiratory Infection were selected from Belgium, France and the Netherlands In a randomised comparative field trial. Each cat underwent a bacteriological examination before treatment (day 0) and received either marbofloxacin, at a dosage of 2 mg/kg once daily for five days, or amoxycillln‐clavulanic acid (ACA) at a dosage of 12·5 mg/kg twice dally for five days. Clinical examinations were performed on days 2, 5 and 14. Pasteurella species were cultured in one‐third of the samples. The other main bacteria isolated were Streptococcaceae, Enterobacterlaceae and Staphylococcaceae. Response rates (cures + improvements) to treatment on day 5 were 87·8 vs 77·8 per cent for marbofloxacin and ACA, respectively. A few mild side‐effects (diarrhoea, vomiting) were recorded with both drugs.